|
Elements
of multiplicity
Everyone desires to be well known in all segments with their
existing strengths. Usha Sharma tracks the expansion moves
of many pharmaceutical, food and cosmetic players which are
willing to cross step on the multi normed mesh of multi edged
common ingredients.
Clinsys
CRO acquires Canadian firm TrialStat
Clinsys Clinical Research, a subsidiary of Jubilant Organosys
has acquired Canadian electronic data capture (EDC) company
TrialStat ClinicalAnalytics (TrialStat CA) from TrialStat
for a purchase consideration of C$750,000
Maharashtra
and Delhi FDA exposes Kamagra drug rackets
The Maharashtra Police and Food and Drugs Administration (FDA)
officials have recently busted a spurious drugs racket in
Mumbai
Elder
inks pact with Daiwa Pharma
Elder Pharmaceuticals has entered into an in-licensing agreement
with Tokyo-based nutraceutical company, Daiwa Pharmaceutical,
for introducing the latter's nutraceuticals products into
the Indian markets
Wanbury
explores osteoporosis and gynaecology segment
Wanbury recently entered into the osteoporosis and gynaecology
related calcium deficiency market
ICRI
allies with Singapore Health
Institute of Clinical Research India (ICRI) has entered into
a partnership with Singapore based healthcare institution
Singapore Health
Maneesh
Pharma to set up new facility at Baddi
Maneesh Pharmaceuticals is setting up its new manufacturing
unit at Baddi
ICC
urges pharma companies to manufacture kala-azar drugs
The Indian Chemical Council (ICC), the national body of chemical
manufacturers, is planning to urge its member pharmaceutical
companies to venture into manufacturing of drugs to combat
and eradicate 'visceral leishmaniasis' or kala-azar, as larger
sections of the society cannot afford the expensive foreign
drugs
Strides
obtains ANDA approval for sterile product
Strides Arcolab (Strides) has received an Abbreviated New
Drug Application (ANDA) approval for pamidronate disodium
injection
Piramal
Healthcare to expand its presence
Piramal Healthcare Ltd (PHL) is investing Rs 20 crore for
setting up its new manufacturing facility at Baddi, designed
as per US Food and Drug Administration (FDA) guidelines
GSK
partners with Kemwell to set up R&D facility
Kemwell, a pharmaceutical contract manufacturer, has set up
a new R&D facility in Bangalore, in partnership with the
world's leading pharma company, GlaxoSmithKline (GSK)
‘Media
is a carbon-carbon double bond between IPC and delegates’
Atul Kumar Nasa, Organising Secretary—Local Organising
Committee, 60th Indian Pharmaceutical Congress, gives Sonal
Vij an update on preparations for the Congress
Event
Brief
AmeriCares
launches India operations, appoints Dr Purvish M Parikh as
MD
AmeriCares, an international disaster relief and humanitarian
aid organisation, formally launched its expanded operations
in India on November 5 2008, and appointed Dr Purvish M Parikh,
distinguished oncologist and nonprofit leader, as Managing
Director of AmeriCares India
Belgium
and India—two complementary and growing biopharma clusters
The Indian-belgium BioPharma Forum commenced on 6th November
2008 in Mumbai
A
class on pharmacovigilance
The Nizam's Institute of Medical Sciences (Dept. of Clinical
Pharmacology and Therapeutics), Hyderabad in association with
MakroCare, a global clinical services firm, successfully organised
the workshop on Pharmacovigilance, in Hyderabad on November
14, 2008 to impart basic and fundamental knowledge and information
on pharmacovigilance practices
|
